Smart manufacturing is “nearly universal” with 95% of manufacturers saying they are using or evaluating smart technology, according to a new survey from Rockwell Automation.
The CDMO completed site construction and infrastructure installation at its 50,000-square-foot facility, with full-scale GMP production slated for this summer.
U.S. Pharmacopeia CEO Ronald Piervincenzi told lawmakers that advanced manufacturing technologies will better enable production of pharmaceuticals and pharma ingredients.
Part of Danaher Corporation, Cytiva’s strategic investment in Asia-Pacific, Europe, and the United States aligns with its long-term growth plan to better serve customers.
While Big Pharma companies have announced $270 billion in domestic investments, lab leasing declined significantly in Q1 2025, finds JLL’s U.S. Life Sciences Property Report.
The partnership between the biopharma company and CDMO is expected to improve yield and upgrade analytical methods ahead of clinical use and regulatory submissions.
The new site precedes the opening of a Yokohama manufacturing facility slated to be operational in 2027 with services for biologics, cell therapies, and messenger RNA.
The site in Hopewell will now incorporate an additional 26,000 square feet of drug substance manufacturing suites, laboratories, storage, dispensing and warehousing.
The CDMO is entering the advanced therapy manufacturing space with the installation of its third FlexFactory platform from Cytiva to meet demand for genomic medicines.
Three of Cognite's chemical, refining, and energy customers take center stage in this product tour video that showcases why and how they are transforming their operations.
Are you making quick-enough progress on your industrial Gen AI journey? Learn what it actually takes to trust, deliver, and scale across operational use cases.
Optimize safety, efficiency, and compliance in biopharma fluid handling with this essential guide to managing single-use bioprocess bags. Learn how modular, ergonomic, and contamination...
Contract development and manufacturing organizations (CDMOs) are more critical than ever to the biopharmaceutical industry, providing essential outsourcing services to customers...
